Spruce Biosciences, Inc. Payments of Stock Issuance Costs
Spruce Biosciences, Inc. (SPRB) reported Payments of Stock Issuance Costs of $6.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-05-06
- Spruce Biosciences, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $6.00K.
- Spruce Biosciences, Inc. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00.
- Spruce Biosciences, Inc. payments of stock issuance costs for the quarter ending 2024-09-30 was $0.00.
- Spruce Biosciences, Inc. payments of stock issuance costs for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Spruce Biosciences, Inc. payments of stock issuance costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Spruce Biosciences, Inc. payments of stock issuance costs for fiscal 2023 was $2.72M, a 875.27% increase from fiscal 2022.
- Spruce Biosciences, Inc. payments of stock issuance costs for fiscal 2022 was $279.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-03-31 | $6.00K 10-Q · filed 2025-05-06 | $6.00K derived: sum of 2 quarters · filed 2025-05-06 | $6.00K derived: sum of 3 quarters · filed 2025-05-06 | $6.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 derived: sum of 3 quarters · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-05-06 | $0.00 derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-05-06 | $0.00 derived: sum of 3 quarters · filed 2025-05-06 | $62.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $62.00K derived: sum of 3 quarters · filed 2025-04-15 | $2.72M 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $62.00K derived: sum of 2 quarters · filed 2024-11-12 | $2.72M 10-Q · filed 2024-11-12 | $2.72M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $2.72M 10-Q · filed 2024-08-12 | $2.72M derived: sum of 3 quarters · filed 2024-08-12 | $2.77M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $2.66M 10-Q · filed 2024-05-13 | $2.66M derived: sum of 2 quarters · filed 2024-05-13 | $2.71M derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $52.00K derived: sum of 2 quarters · filed 2024-03-18 | $279.00K 10-K · filed 2024-03-18 | |
| 2022-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $277.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $227.00K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |